Citation 74089

PETTIT,GR: SINGH,SB: BOYD,MR: HAMEL,E: PETTIT,RK: SCHMIDT,JM: HOGAN,F:. (1995). ANTINEOPLASTIC AGENTS. 291. ISOLATION AND SYNTHESIS OF COMBRETASTATINS A-4, A-5, A-6-1-A.. 38(10)

Citation Details

TitleANTINEOPLASTIC AGENTS. 291. ISOLATION AND SYNTHESIS OF COMBRETASTATINS A-4, A-5, A-6-1-A.
AuthorsPETTIT,GR: SINGH,SB: BOYD,MR: HAMEL,E: PETTIT,RK: SCHMIDT,JM: HOGAN,F:
Year1995
Volume38
Issue10

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Combretum caffrum (COMBRETACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
COMBRETASTATIN A-4
None
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
COMBRETASTATIN A-4
STRONG ACTIVITY
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
COMBRETASTATIN A-4
ACTIVE
4
LYMPHOCYTE PROLIFERATION STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
COMBRETASTATIN A-4
ACTIVE
5
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-4
ACTIVE
6
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-4
INACTIVE
7
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-4
INACTIVE
8
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-4
INACTIVE
9
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-4
INACTIVE
10
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-4
INACTIVE
11Not specified
COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
COMBRETASTATIN A-5
None
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
COMBRETASTATIN A-5
ACTIVE
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
COMBRETASTATIN A-5
ACTIVE
14
TUBULIN POLYMERIZATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
COMBRETASTATIN A-5
ACTIVE
15
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-5
ACTIVE
16
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-5
INACTIVE
17
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-5
INACTIVE
18
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-5
INACTIVE
19
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-5
INACTIVE
20
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-5
INACTIVE
21Not specified
COMPLETE SYNTHESIS REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
COMBRETASTATIN A-6
None
22
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
COMBRETASTATIN A-6
WEAK ACTIVITY
23
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
COMBRETASTATIN A-6
INACTIVE
24
TUBULIN POLYMERIZATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
COMBRETASTATIN A-6
ACTIVE
25
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-6
ACTIVE
26
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-6
INACTIVE
27
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-6
INACTIVE
28
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-6
INACTIVE
29
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-6
INACTIVE
30
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
COMBRETASTATIN A-6
INACTIVE
Show SPARQL Queries (1)